Back to top
more

Veeva Systems (VEEV)

(Real Time Quote from BATS)

$222.78 USD

222.78
527,560

+6.33 (2.92%)

Updated Nov 7, 2024 01:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 251)

Industry: Internet - Software

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Veeva (VEEV) MedTech Suite to Aid B. Braun Speed Up Trials

by Zacks Equity Research

Adoption of Veeva's (VEEV) unified suites of cloud applications is likely to provide a significant boost to the company's Veeva Development Cloud business.

Reasons to Hold on to Veeva Systems (VEEV) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Veeva Systems (VEEV) on its slew of partnerships and robust product adoptions.

Veeva Systems (VEEV) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Veeva (VEEV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Veeva Systems (VEEV) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

Veeva Systems' (VEEV) fiscal second-quarter results are likely to reflect solid show by its segments and robust product portfolio.

Veeva Systems (VEEV) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, Veeva Systems (VEEV) closed at $322.44, marking a +0.54% move from the previous day.

Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Veeva Systems (VEEV) closed at $319.22, marking a -0.8% move from the previous day.

Veeva Systems (VEEV) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Veeva Systems (VEEV) closed at $332.34 in the latest trading session, marking a -1.91% move from the prior day.

Veeva Systems (VEEV) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Veeva Systems (VEEV) closed at $332.78 in the latest trading session, marking a +0.02% move from the prior day.

Catalent (CTLT) Boosts Portfolio Via Launch of GPEx Lightning

by Zacks Equity Research

Catalent's (CTLT) latest product is aimed at improving customer service by speeding up the drug substance development process.

PacBio (PACB) Enhances Sequencing Platform Via Latest Buyout

by Zacks Equity Research

PacBio's (PACB) latest acquisition is expected to deliver the most advanced blend of sequencing solutions to transform the genomics landscape.

Madeleine Johnson headshot

Bear of the Day: Sabre Corp. (SABR)

by Madeleine Johnson

Covid-19 is still weighing on this travel technology provider.

Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Veeva Systems (VEEV) on its slew of partnerships and robust product adoptions.

Dexcom's (DXCM) Digital Network Benefits From Latest FDA Nod

by Zacks Equity Research

Recent regulatory clearance of Dexcom's (DXCM) real-time APIs is expected to aid diabetics as well as their care providers in accessing GCM data.

Debanjana Dey headshot

MedTech Thrives on Healthcare IT in 2021: 4 Stocks to Focus on

by Debanjana Dey

Health IT stocks like HealthEquity (HQY), Veeva Systems (VEEV), Tabula Rasa (TRHC) and Allscripts (MDRX) are expected to continue their run over the next few months.

Catalent (CTLT) Inks Deal for Feasibility Study of CBD Product

by Zacks Equity Research

Catalent's (CTLT) latest agreement is expected to lead to a prototype development of a Zydis formulation via a feasibility study.

Looking for Computer and Technology Stocks? The Zacks Rank Can Help You Find Winners

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.

3 Reasons to Add LHC Group (LHCG) Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about LHC Group (LHCG) owing to its slew of deals and a broad array of services.

OPKO Health (OPK) Inks Licensing Deal for AntagoNAT Technology

by Zacks Equity Research

OPKO Health's (OPK) latest licensing agreement is expected to advance the development and commercialization of potential disease-modifying therapeutics, especially for Dravet syndrome.

Inogen (INGN) Hits New 52-Week High: What's Driving It?

by Zacks Equity Research

Investors are optimistic about Inogen's (INGN) direct-to-customer business model and a strong product portfolio.

BD's (BDX) Digital Marketplace Set to Improve User Experience

by Zacks Equity Research

BD's (BDX) latest online marketplace is expected to offer a better user experience to its flow cytometry users.

Smith+Nephew's (SNN) New Device to Boost Patient Outcomes

by Zacks Equity Research

Smith+Nephew's (SNN) FAST-FLIX FLEX Meniscal Repair System to provide long-term benefits to patients.

Here's Why You Should Retain Merit Medical (MMSI) Stock Now

by Zacks Equity Research

Merit Medical (MMSI) continues to gain traction from robust Peripheral Intervention arm and solid international presence. Forex, although, remains a concern.

McKesson (MCK) Enters Deal to Divest Some European Businesses

by Zacks Equity Research

McKesson (MCK) to sell off some of its European ventures to streamline its business and prioritize investments in areas where it has better expertise.

The Zacks Analyst Blog Highlights: Zoom, Digital Turbine, ServiceNow and Veeva Systems

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Zoom, Digital Turbine, ServiceNow and Veeva Systems

Ritujay Ghosh headshot

4 Stocks to Buy on Increased Cloud Infrastructure Spending

by Ritujay Ghosh

The cloud-based service market has been growing in importance since the coronavirus outbreak, helping companies like Digital Turbine (APPS), Zoom Video Communications (ZM) and ServiceNow (NOW).